Laddar...
Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly
PURPOSE: Cushing’s disease (CD) and acromegaly are characterized by excessive hormone secretion resulting in comorbidities such as impaired glucose metabolism, diabetes and hypertension. Pasireotide is a new-generation, multireceptor-targeted somatostatin receptor ligand approved for CD (subcutaneou...
Sparad:
| I publikationen: | Pituitary |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer US
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4996868/ https://ncbi.nlm.nih.gov/pubmed/27405306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11102-016-0734-1 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|